赵维教授
暂无内容
- [41] Wang, Ya-Kun. Optimal Dosing of Ceftriaxone in Infants Based on a Developmental Population Pharmacokinetic-Pharmacodynamic Analysis. Antimicrobial Agents and Chemotherapy, 64, 2020.
- [42] Muhammad Wasim Khan . Population pharmacokinetics and dose optimization of ceftriaxone for children with community-acquired pneumonia. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 76, 1547, 2020.
- [43] 阚敏. Cefotiam Treatment in Children: Evidence of Subtherapeutic Levels. THERAPEUTIC DRUG MONITORING, 42, 733, 2020.
- [44] 吴月娥. Population Pharmacokinetics and Dosing Optimization of Amoxicillin in Chinese Infants. JOURNAL OF CLINICAL PHARMACOLOGY, 2020.
- [45] 李谦. Determination of Loratadine and Its Active Metabolite in Plasma b LC/MS/MS: An Adapted Method for Children. CURRENT PHARMACEUTICAL ANALYSIS, 16, 909, 2020.
- [46] 阚敏. An adapted LC-MS/MS method for the determination of free plasma concentration of cefoperazone in children: Age-dependent protein binding. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 1144, 2020.
- [47] Ye, Pan-Pan. First dose in neonates: pharmacokinetic bridging study from juvenile mice to neonates for drugs metabolized by CYP3A. XENOBIOTICA, 50, 1275, 2020.
- [48] 周岳. Drug Elimination Alteration in Acute Lymphoblastic Leukemia Mediated by Renal Transporters and Glomerular Filtration. PHARMACEUTICAL RESEARCH, 37, 2020.
- [49] 吴月娥 , 郑义 and 赵维. A Sensitive Microscale HPLC-UV Method for The Determination of Doxofylline and Its Metabolites In Plasma: An Adapted Method for Therapeutic Drug Monitoring in Children. CURRENT PHARMACEUTICAL ANALYSIS, 47, 2020.
- [50] 杨新美 and 赵维. Body Surface Area-Based Dosing Regimen of Caspofungin in Children: a Population Pharmacokinetics Confirmatory Study. Antimicrobial Agents and Chemotherapy, 63, 2019.
- [51] Dong, Lei and 赵维. Population Pharmacokinetics and Dosing Optimization of Imipenem in Children with Hematological Malignancies. Antimicrobial Agents and Chemotherapy, 63, 2019.
- [52] Jacqz-Aigrain, Evelyne and 赵维. Population pharmacokinetic meta-analysis of individual data to design the first randomized efficacy trial of vancomycin in neonates and young infants. J Antimicrob Chemother, 74, 2128, 2019.
- [53] 汤博皓 , 赵维 and 郑义. Population Pharmacokinetics and Dosing Optimization of Amoxicillin in Neonates and Young Infants. Antimicrobial Agents and Chemotherapy, 63, 2019.
- [54] Qi, Hui , 郑义 and 赵维. Population pharmacokinetics and dosing optimization of latamoxef in neonates and young infants. International Journal of Antimicrobial Agents, 53, 347, 2019.
- [55] Sun, Su-Zhen and 赵维. Aciclovir CSF concentration in children with viral encephalitis: is it adequate?. Journal of Antimicrobial Chemotherapy, 73, 2582, 2018.
- [56] 赵维 and 赵维. Clinical Utility and Safety of a Model-Based Patient-Tailored Dose of Vancomycin in Neonates.. Antimicrobial Agents and Chemotherapy, 2016.
- [57] 郑义 , 赵维 , 郝国祥 and 郝国祥. Population pharmacokinetics of tacrolimus in children with nephrotic syndrome. British Journal of Clinical Pharmacology, 84, 1748, 2018.
- [58] 赵维 and 赵维. First dose in neonates: are juvenile mice, adults and in vitro-in silico data predictive of neonatal pharmacokinetics of fluconazole. Clinical Pharmacokinetics, 53, 1005, 2014.
- [59] 赵维 and 赵维. Dosage individualization in children: integration of pharmacometrics in clinical practice. WORLD JOURNAL OF PEDIATRICS, 10, 197, 2014.
- [60] 赵维 and 赵维. Choosing the right dose of tacrolimus. Archives of Disease in Childhood, 2014.